Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246582 · ClinicalTrials.gov registry record · NA
Adult Accuracy Study of the Enlite 3 Glucose Sensor
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
NCT02246582: Completed NA study, sponsored by Medtronic MiniMed.
NCT02246582 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 118 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02246582, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and 640G Pump in subjects aged 14-75 years with type 1 or type 2 diabetes.
Interventions
- DEVICE Enlite 3
- DEVICE Guardian Mobile App
- DEVICE 640G Insulin Pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02246582
The ClinicalTrials.gov registry entry for NCT02246582 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Enlite 3 is the first listed.
NCT02246582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02246582 about?
NCT02246582 is a clinical study titled "Adult Accuracy Study of the Enlite 3 Glucose Sensor". The purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and 640G Pump in subjects aged 14-75 years with type 1 or type 2 diabetes.
What is the current status of trial NCT02246582?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2014-09. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02246582?
The interventions under investigation include: Enlite 3 (DEVICE), Guardian Mobile App (DEVICE), 640G Insulin Pump (DEVICE).
Who is sponsoring clinical trial NCT02246582?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.